LENALIDOMIDE for Plasma cell myeloma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 273,951 adverse event reports in the FDA FAERS database where LENALIDOMIDE was used for Plasma cell myeloma.
Most Reported Side Effects for LENALIDOMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 27,576 | 7.9% | 545 | 4,623 |
| Fatigue | 22,956 | 6.6% | 444 | 2,907 |
| Death | 19,213 | 5.5% | 19,190 | 1,415 |
| Off label use | 17,017 | 4.9% | 1,252 | 3,116 |
| Rash | 15,794 | 4.5% | 315 | 1,830 |
| Pneumonia | 14,807 | 4.2% | 1,646 | 11,418 |
| Plasma cell myeloma | 14,191 | 4.1% | 5,427 | 2,477 |
| Neuropathy peripheral | 10,215 | 2.9% | 210 | 988 |
| White blood cell count decreased | 9,996 | 2.9% | 176 | 1,895 |
| Constipation | 9,635 | 2.8% | 183 | 1,395 |
| Nausea | 9,206 | 2.6% | 250 | 1,848 |
| Asthenia | 8,192 | 2.3% | 424 | 2,679 |
| Product dose omission issue | 8,145 | 2.3% | 24 | 691 |
| Platelet count decreased | 7,491 | 2.1% | 397 | 1,855 |
| Neutropenia | 6,909 | 2.0% | 670 | 1,451 |
Other Indications for LENALIDOMIDE
Product used for unknown indication (20,069)
Myelodysplastic syndrome (14,132)
Diffuse large b-cell lymphoma (7,858)
Off label use (5,767)
Plasma cell myeloma in remission (4,678)
Follicular lymphoma (3,611)
B-cell lymphoma (3,474)
Mantle cell lymphoma (2,989)
Non-hodgkin's lymphoma (2,744)
Plasma cell myeloma recurrent (2,451)
Other Drugs Used for Plasma cell myeloma
POMALIDOMIDE (81,096)
DEXAMETHASONE (49,067)
BORTEZOMIB (31,567)
DARATUMUMAB (19,119)
IXAZOMIB (17,602)
CARFILZOMIB (15,333)
THALIDOMIDE (10,689)
CYCLOPHOSPHAMIDE (9,148)
REVLIMID (7,122)
SELINEXOR (5,659)